Focus on the international biomedicine frontier race track: the type 2 diabetes living biological drug pipeline was officially launched in Zhangjiang Pharmaceutical Valley
On October 8, under the witness of the General Health Professional Committee of Shanghai Modern Service Industry Federation, Zhangjiang Living diabetes II (T2D) Living Biological Drug (LBP) pipeline of Zhangjiang Living Biological Drug Research and Development Center was officially launched. Jian Danian, Vice President of Shanghai Modern Service Industry Federation, stated that the federation will continue to closely adhere to Shanghai's modern industrial system and introduce more high-level technology enterprises to Pudong and Zhangjiang...
Global Cell therapy will welcome the blowout of diabetes and open a new era of cell therapy
With the continuous efforts of domestic and foreign pharmaceutical companies in research and development, the global cell therapy track is accelerating into a harvest period.In addition to being successively approved for listing in the field of cancer, cell therapy has also achieved breakthroughs in the field of diabetes...